Author: Lamazou, F.; Oger, P.; Dieli-crimi, R.; Guerin, A.; Letouzey, V.; Octernaud, S.; Place, V.; Calès, P.; Descamps, P.; Delaroche, L.
Title: COVID-19 infection in first trimester of pregnancy marked by a liver cytolysis in a woman previously treated by hydroxychloroquine for repeated implantation failure: a case report Cord-id: a3gdcgke Document date: 2020_11_16
ID: a3gdcgke
Snippet: BACKGROUND: In December 2019, a new disease (COVID-19) caused by a novel coronavirus called SARS-CoV-2 emerged in China and spread to many other countries. There is only limited data about the clinical features of COVID-19 during pregnancy, especially in first trimester. CASE PRESENTATION: We report a COVID-19 infection in a 35 years-old patient in first trimester of pregnancy and its consequent medical care. At 7 weeks of pregnancy, the patient, who did not have any pregestational comorbidities
Document: BACKGROUND: In December 2019, a new disease (COVID-19) caused by a novel coronavirus called SARS-CoV-2 emerged in China and spread to many other countries. There is only limited data about the clinical features of COVID-19 during pregnancy, especially in first trimester. CASE PRESENTATION: We report a COVID-19 infection in a 35 years-old patient in first trimester of pregnancy and its consequent medical care. At 7 weeks of pregnancy, the patient, who did not have any pregestational comorbidities, complained of intense nausea and asthenia. An important liver cytolysis was discovered with biological perturbations of transaminases levels. No respiratory symptoms were recorded. Classical viral aetiologies and drug-related toxicity were discarded. Because of the aggravation of the symptoms and the occurrence of the breathlessness, the patient was tested for the COVID-19 in a nasopharyngeal swab. The RTq-PCR assay indicated the presence of SARS-CoV-2 RNA. In the absence of severe symptoms, the patient was monitored at home according to the French government guidelines. After a few days, the symptoms resolved without any complications. The pregnancy is still ongoing without any visible sequelae on the foetus so far. CONCLUSIONS: This first case illustrated the difficulty of COVID-19 diagnosis in patients with isolated digestive symptoms in first trimester of pregnancy that could be confused with gravida hyperemesis. Monitoring of pregnancy after an episode of COVID-19 should be strengthened with bimonthly foetal growth ultrasounds and doppler assessments because of the risks for intrauterine growth restriction. Comprehensive data on larger numbers of first trimester gravid women with COVID-19 are required to better understanding the overall impact of SARS-CoV-2 on maternal and birth outcomes.
Search related documents:
Co phrase search for related documents- abdominal pain and abnormal liver: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- abdominal pain and abnormal liver function: 1, 2, 3, 4, 5, 6
- abdominal pain and liver bile duct: 1, 2
- abdominal pain and liver bile duct normal: 1
- abdominal pain and liver damage: 1, 2, 3, 4, 5, 6, 7, 8
- abdominal pain and liver enzyme: 1, 2, 3, 4, 5, 6, 7, 8
- abdominal pain and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- abdominal pain and liver function impairment: 1
- abdominal pain vomiting and abnormal aminotransferase level: 1, 2
- abdominal pain vomiting and abnormal liver: 1, 2, 3, 4, 5, 6, 7, 8
- abdominal pain vomiting and abnormal liver function: 1, 2, 3, 4
- abdominal pain vomiting and liver bile duct: 1
- abdominal pain vomiting and liver bile duct normal: 1
- abdominal pain vomiting and liver damage: 1, 2, 3, 4, 5, 6
- abdominal pain vomiting and liver enzyme: 1, 2, 3, 4, 5, 6, 7
- abdominal pain vomiting and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- abdominal pain vomiting and liver function impairment: 1
- abdominal pain vomiting diarrhea and abnormal aminotransferase level: 1, 2
- abdominal pain vomiting diarrhea and abnormal liver: 1, 2, 3, 4
Co phrase search for related documents, hyperlinks ordered by date